Irisin levels exhibit a robust correlation with health status, revealing markedly diminished levels in individuals afflicted with obesity, osteoporosis, reduced bone mass, muscular dystrophy, and cardiovascular disease, while cancer patients manifest elevated irisin levels (80). This evidence concerns the gene FNDC5 and osteoporosis.